Embrace Molecule Complexity With Optimized Expression Technologies

Biologic drugs are increasingly complex, creating numerous challenges for biopharmaceutical companies, from higher candidate failure rates to expression and manufacturing obstacles. Lonza's Mammalian and Microbial expression systems and processes address the needs of more complex candidates, including vector design, cell line and strain selection and analytics to measure product quality attributes. In this webinar, case studies are discussed demonstrating the range of expression capabilities across mammalian and microbial derived molecules.

Who Should Watch This Webinar

Anyone active in:

• Drug Substance Manufacturing
• Drug Discovery
• Executive Management, covering multiple areas
• Outsourcing / Purchasing & Procurement
• Preclinical Product Development
• Process Development
• Quality Assurance / Quality Control
• Research & Development / R&D Management
• Regulatory / Compliance